Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20199969 | 0.94 | SIGMAR1 (0.35) | KDM4EALDH1A1SIGMAR1MDM2S1PR1 | |
| SCHEMBL20199971 | 0.85 | ALDH1A1 (0.35) | KDM4EALDH1A1SIGMAR1MDM2HSD17B10 | |
| SCHEMBL20200027 | 0.85 | HSD17B10 (0.39) | KDM4EALDH1A1SIGMAR1MDM2S1PR1 | |
| SCHEMBL22069385 | 0.84 | SIGMAR1 (0.33) | KDM4EALDH1A1SIGMAR1MDM2HSD17B10 | |
| SCHEMBL22112401 | 0.81 | SIGMAR1 (0.34) | KDM4EALDH1A1SIGMAR1MDM2S1PR1 | |
| SCHEMBL22069505 | 0.79 | HSD17B10 (0.37) | KDM4EALDH1A1MEN1KMT2AHSD17B10 | |
| SCHEMBL20188998 | 0.78 | KDM4E (0.48) | KDM4EALDH1A1SIGMAR1MDM2S1PR1 | |
| SCHEMBL20200037 | 0.77 | BLM (0.35) | KDM4EALDH1A1SIGMAR1MDM2KMT2A | |
| SCHEMBL29834060 | 0.76 | KDM4E (0.47) | KDM4EALDH1A1SIGMAR1MDM2S1PR1 | |
| SCHEMBL22403101 | 0.75 | HSD17B10 (0.35) | KDM4EALDH1A1HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018096082-A1 | HIGH RELAXIVITY GADOLINIUM CHELATE COMPOUNDS FOR USE IN MAGNETIC RESONANCE IMAGING | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-05-31 | — | — | WO | disclosed |